MiMedx Group (NASDAQ:MDXG) Releases Earnings Results, Meets Expectations

MiMedx Group (NASDAQ:MDXG) issued its quarterly earnings data on Wednesday. The company reported $0.07 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.07, Zacks reports. MiMedx Group had a net margin of 23.86% and a return on equity of 26.21%.

MiMedx Group Trading Up 0.6 %

NASDAQ MDXG traded up $0.05 on Wednesday, hitting $8.01. 562,154 shares of the company were exchanged, compared to its average volume of 563,991. The company’s 50 day moving average price is $8.78 and its 200-day moving average price is $7.68. The company has a debt-to-equity ratio of 0.10, a current ratio of 4.10 and a quick ratio of 3.53. The firm has a market capitalization of $1.18 billion, a P/E ratio of 14.56 and a beta of 1.94. MiMedx Group has a twelve month low of $5.47 and a twelve month high of $10.14.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut shares of MiMedx Group from a “strong-buy” rating to a “buy” rating in a research report on Friday, November 8th. Six investment analysts have rated the stock with a buy rating, According to MarketBeat, MiMedx Group presently has a consensus rating of “Buy” and an average price target of $12.00.

About MiMedx Group

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.